Results 31 to 40 of about 7,001,427 (209)

Effects of dalcetrapib in patients with a recent acute coronary syndrome [PDF]

, 2012
In observational analyses, higher levels of high-density lipoprotein (HDL) cholesterol have been associated with a lower risk of coronary heart disease events.
Chaitman Bernard R., Nicholls, Stephen J., Mundl, Hardi,, Ballantyne, Christie M,, Nicholls, Stephen J,, Ballantyne, Christie M., Shah, P.K., Ballantyne Christie M., Ballantyne C.M., Chaitman B.R., Wright, R Scott,, McMurray, J.J.V., McMurray, John J V, Mundl, H., Abt Markus, Shah, Prediman K., Schwartz, G.G., McMurray, John J. V., Leiter, Lawrence A,, Leiter, Lawrence A., Barter, Philip J., DE CATERINA, Raffaele, Tardif, Jean-Claude,, Barter, P.J., Leiter L.A., McMurray, J., Brumm, J., Wright, R Scott, Olsson, A.G., Abt, Markus,, Shah Prediman K., dal OUTCOMES Investigators, Leitersdorf, E., Ballantyne, C.M., Kallend, David,, Brumm, Jochen, Mundl Hardi, Shah, Prediman K,, Holme, Ingar M., McMurray, John J V,, Holme, Ingar M,, Brumm Jochen, McMurray J.J., Kallend, David, Goldner, David, Wright, R., Tardif, J., Chaitman, Bernard R,, Wright R. Scott, Shah, P., Chaitman, Bernard R., Chaitman, B., Kallend David, Nicholls, Stephen J, Schwartz Gregory G., Barter, Philip J,, Leiter Lawrence A., Tardif, Jean-Claude, Barter P.J., Barter, P., Abt, Markus, Schwartz, Gregory G., Leiter, Lawrence A, Holme I.M., Olsson, A., The dal-OUTCOMES Investigators, Tardif Jean Claude, Holme, Ingar M, Leitersdorf, Eran, Wright, R.S., Barter Philip J., Schwartz, Gregory G,, Olsson Anders G., Leiter, L.A., Olsson A.G., Olsson, Anders G., Schwartz, Gregory G, Colquhoun, David, Leiter, L., Nicholls, S.J., Barter, Philip J, Chaitman, Bernard R, Brumm, Jochen,, Leitersdorf E., Nicholls, S., Chaitman, B.R., Holme, I.M., Holme, I., Kallend, D., Brumm J., Mundl, Hardi, Shah, Prediman K, Nicholls Stephen J., Wright, R. Scott, McMurray John J. V., Kallend D., Olsson, Anders,, Ballantyne, C., Holme Ingar M., Olsson, Anders G, Abt M., Schwartz G.G., Leitersdorf Eran, Abt, M., Ballantyne, Christie M, Schwartz, G., Leitersdorf, Eran,, GOLINO, Paolo   +107 more
core   +1 more source

UPBEAT-UK: a programme of research into the relationship between coronary heart disease and depression in primary care patients [PDF]

, 2016
Many people with coronary heart disease (CHD) are depressed and research on people who have had a heart attack found that depression increases the chance of further heart attacks.
Elizabeth A Barley, Mann, Anthony, Rose, Diana, Leese, Morven, Barley, E A, Rosemary Simmonds, Murray, J, Palacios, Jorge, Paul Walters, Leese, M, Joanna Murray, McCrone, P, van Marwijk, Harm, Morven Leese, Walters, Paul, Smith, A., Tylee, A, Evanthia Achilla, Paul McCrone, Paul Williams, Simmonds, R, Rohan Borschmann, Mann, A, Smith, Alison, Walters, P, Diana Rose, Borschmann, Rohan, Tylee, Andre, Barley, Elizabeth A., Rose, D, Williams, Paul, Barley, Elizabeth, Achilla, Evanthia, Harm van Marwijk, Williams, P, Alison Smith, Borschmann, R, André Tylee, McCrone, Paul, Van Marwijk, H, on behalf of the UPBEAT-UK team, Simmonds, Rosemary, Murray, Joanna, Jorge Palacios, Palacios, J; id_orcid, Achilla, E, Anthony Mann   +46 more
core   +1 more source

Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention

Cardiovascular Diabetology, 2022
Background It has been demonstrated that glycated albumin (GA) is significantly associated with diabetes complications and mortality. However, among patients diagnosed with non-ST-elevation acute coronary syndrome (NSTE-ACS) administered percutaneous ...
Chi Liu, Qi Zhao, Xiaoteng Ma, Yujing Cheng, Yan Sun, Dai Zhang, Xiaoli Liu, Yujie Zhou   +7 more
doaj   +1 more source

Lipoprotein(a) is associated with coronary heart disease independent of metabolic syndrome [PDF]

, 2008
WOS: 000255571200001PubMed: 18418227Aim To assess (i) the association between lipoprotein(a) [Lp(a)] with the likelihood of coronary heart disease and metabolic syndrome (MS) and (ii) its covariates in Turkish adults.
Kaya, Zekeriya, Hergenç, Gülay, Oezhan, Hakan, Hergenc, Guelay, Onat, Altan, Can, Günay, Bulur, Serkan, Ayhan, Erkan, Özhan, Hakan, Gülay Hergenç, Hakan Özhan, Günay Can, Zekeriya Kaya, Erkan Ayhan, Altan Onat, Serkan Bulur   +15 more
core   +1 more source

Oxidative Stress–Related Genome-Wide Mendelian Randomization Identifies Causal Genes for Coronary Artery Disease

Cardiovascular Therapeutics
Although oxidative stress (OS) links to the pathogenesis of coronary artery disease (CAD), its underlying genetic mechanisms remain unclear. Through summary data–based Mendelian randomization (SMR) and colocalization, this research seeks to assess the ...
Hongliang Zhang, Jingsheng Feng, Wence Shi, Guannan Niu, Yanqin Zheng, Zhenyan Zhao, Moyang Wang, Zheng Zhou, Zhe Li, Yongjian Wu   +9 more
doaj   +1 more source

Systemic immune-inflammation Index is an independent risk factor for Major adverse cardiovascular events in patients with coronary artery ectasia

Frontiers in Cardiovascular Medicine
BackgroundReliable biomarkers for long-term risk stratification in coronary artery ectasia (CAE) remain limited. The systemic immune-inflammation index (SII), derived from routine hematological parameters, reflects the balance between inflammation and ...
Deguang Wang, Jingxian Xing, Zhaoqing Xie, Yunlong Zhang, Yunjie Wu, Tao Geng   +5 more
doaj   +1 more source

Regeneration of the heart: from molecular mechanisms to clinical therapeutics

Military Medical Research, 2023
Heart injury such as myocardial infarction leads to cardiomyocyte loss, fibrotic tissue deposition, and scar formation. These changes reduce cardiac contractility, resulting in heart failure, which causes a huge public health burden.
Qian-Yun Guo, Jia-Qi Yang, Xun-Xun Feng, Yu-Jie Zhou   +3 more
doaj   +1 more source

Psychological distress, physical illness, and risk of coronary heart disease [PDF]

, 2005
Study objective: The aims of this study are to confirm the association between psychological distress and coronary heart disease (CHD) using an epidemiological community study with hospital admissions data and to examine if any association is explained ...
Rasul, F., Stansfeld, S.A., Stansfeld, SA, Hart, CL, Davey Smith, G., Hart, C.L., Rasul, F, Davey Smith, G   +7 more
core   +1 more source

Association of sodium-glucose cotransporter 2 inhibitors with risk of major adverse cardiovascular events in type 2 diabetes patients with acute coronary syndrome: a propensity score‑matched analysis

Cardiovascular Diabetology
Background This study aimed to investigate the association of sodium-glucose cotransporter 2 inhibitors (SGLT2i) use with cardiovascular (CV) clinical outcomes in type 2 diabetes (T2D) patients with acute coronary syndrome (ACS).
Tao Liu, Zeyuan Fan, Bing Xiao, Chang He, Shicong Wang   +4 more
doaj   +1 more source

Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Stage 4 Cardiovascular–Kidney–Metabolic Syndrome: A Propensity Score–Matched Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background This study investigated the effects of sodium–glucose cotransporter 2 inhibitors (SGLT2is) on patients with stage 4 cardiovascular–kidney–metabolic syndrome over 1 year.
Tao Liu, Zeyuan Fan, Yuntao Li, Bing Xiao, Chang He   +4 more
doaj   +1 more source